NCT07485816

Brief Summary

At different stages of heart failure (HF), the cardiac and cerebral oxygen reserve exhibits varying degrees of decline due to chronic hypoxia and microvascular dysfunction caused by reduced cardiac output, leading to cognitive dysfunction. As a direct marker of microvascular function, early identification and intervention of cardiac and cerebral oxygen reserve are crucial to prevent irreversible damage to organs such as the heart and brain. However, there is currently no precise and effective method to quantify cardiac and cerebral oxygen reserve. Oxygen-sensitive magnetic resonance imaging (OS-MRI), as an emerging functional imaging technique, can dynamically monitor oxygenation changes and oxygen reserve capacity in Homo sapiens tissues. However, due to its technical complexity, its application in combined cardiac and cerebral assessment in HF patients remains underexplored. This prospective, single-center cohort study employs OS-MRI combined with respiratory maneuvers to examine the heart and brain in HF patients at different stages. Continuous image acquisition is performed during hyperventilation to breath-holding, and myocardial oxygen reserve (MORE) and cerebral oxygen reserve (CORE) are derived using MATLAB and CVI42 post-processing software. Cognitive function is assessed using the Montreal Cognitive Assessment (MoCA) scale, with scores \<26 indicating mild cognitive dysfunction. Subsequently, SPSS is used to analyze the correlation between cardiac/cerebral oxygen reserve and MoCA scores, providing imaging-based evidence for early clinical detection of oxygen reserve decline in HF patients and confirming the potential link between cardiac/cerebral oxygen reserve, HF, and cognitive dysfunction.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
4mo left

Started Mar 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
Mar 2026Oct 2026

Study Start

First participant enrolled

March 15, 2026

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

March 16, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 20, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2026

Last Updated

March 20, 2026

Status Verified

March 1, 2026

Enrollment Period

7 months

First QC Date

March 16, 2026

Last Update Submit

March 16, 2026

Conditions

Keywords

Heart Failure, cardio-cerebral oxygenation reserve, cognitive dysfunction, OS-MRI

Outcome Measures

Primary Outcomes (1)

  • Cognitive function decline

    The MoCA scoreless than 26 points is considered to indicate cognitive dysfunction

    Within after MRI scanning 24 hours

Study Arms (2)

Heart Failure Patients group

enrolled NYHA II-IV level heart failure patients

Behavioral: breathing training

Healthy Control group

confirmed to have no ischemic heart disease by physical examination and echocardiography, will be recruited.

Behavioral: breathing training

Interventions

Before MRI scanning, participant will trained to exhale and hold their breath

Healthy Control groupHeart Failure Patients group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

NYHA classification II=IV heart failure patients and age- and sex-matched control group

You may qualify if:

  • Aged \>18 years and \<70 years. (2)Hospitalized for HF or clinically diagnosed with HF and admitted as an inpatient

You may not qualify if:

  • (1)Concurrent severe non-cardiac oxygen metabolism diseases (e.g., severe Chronic Obstructive Pulmonary Disease (COPD) or end-stage renal failure). (2)Myocardial infarction or stroke within the last 90 days. (3)Contraindications to MRI. (4)Inability to cooperate with the examinations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yan'an Hospital Affiliated to Kunming Medical University

Kunming, Yunnan, 650051, China

Location

MeSH Terms

Conditions

Heart FailureCognitive Dysfunction

Interventions

Breathing Exercises

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesCognition DisordersNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsExercise Movement TechniquesPhysical Therapy Modalities

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Student

Study Record Dates

First Submitted

March 16, 2026

First Posted

March 20, 2026

Study Start

March 15, 2026

Primary Completion (Estimated)

October 15, 2026

Study Completion (Estimated)

October 15, 2026

Last Updated

March 20, 2026

Record last verified: 2026-03

Locations